Hempstreet Medicare

What Hempstreet Medicare does

Hempstreet Medicare Private Limited, operating as HempStreet, is a research-to-retail Ayurvedic cannabis venture founded in 2019 and headquartered in India (firmographics list New Delhi; one source references Gurgaon legal jurisdiction). The company develops and dispenses cannabis-based classical Ayurvedic formulations targeting mass ailments in India, with primary focus on chronic pain management (cancer pain, neuropathic pain, postoperative pain) and women's health (menstrual cramps/dysmenorrhea). End patients are reached indirectly through a prescription-based model requiring consultation with certified Ayurvedic practitioners (BAMS/BHMS-qualified), positioning the company in a regulated intersection of traditional Ayurveda and modern phytopharmaceutical research.

The product portfolio comprises 300+ Ayurvedic formulations anchored by the flagship Trailokya Vijaya Vati — a classical formulation featuring Vijaya (medical cannabis) that interacts with the endocannabinoid system to modulate pain response. Complementary SKUs include Bilwadi Churna for digestive/IBS conditions, Kameshwar Modaka variants for pain management, Sarpagandha Ghan Vati for hypertension, Manmath Ras for sexual wellness, and Formulation Humane for cancer pain and palliative care. The company also co-developed ArtemiC, a nutraceutical mouth spray for COVID-19 symptoms, with MGC Pharma. Technology combines classical Ayurvedic texts with modern research methodology, including India's first clinical trials for menstrual cramps in partnership with Amrita School of Ayurveda.

HempStreet's commercial model is dual-channel: direct-to-patient e-commerce via hempstreet.in/shop and itshemp.in/hs (with free practitioner consultations as a freemium entry point), and prescription-based dispensing through a network of 60,000+ Ayurvedic practitioners across 18,000+ clinics. Revenue is generated from one-time product sales and professional consultation services. The company has raised a $1 million pre-Series A round in November 2023 led by Carl Waahlin, alongside prior investment from Pharmacon Holdings (February 2020) and a Rs. 50 lakh BIRAC Biotechnology Ignition Grant (2021) — the first such grant for a medicinal cannabis company in India. The website platform is authored and published by Wellbeing Healthtech Pvt. Ltd., which appears to be an affiliated or parent-entity relationship rather than a disclosed subsidiary.

Name

Hempstreet Medicare

Legal name

Hempstreet Medicare Private Limited

Website

https://hempstreet.in

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Hempstreet Medicare is India's first research-to-retail venture in Ayurvedic medicinal cannabis, dispensing classical cannabis-based formulations through a network of 60,000+ Ayurvedic practitioners and 18,000+ clinics, primarily serving chronic pain and women's health patients.

Ownership category

akta.pro rank

Product category

Ayurvedic Medicinal Cannabis

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmacies and Drug Retailers (45611), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)

akta.pro secondary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

Keywords

• Ayurvedic cannabis medicines
• Herbal pain management
• Medicinal cannabis products
• Cannabis based formulations
• Ayurvedic practitioner network

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Product Sales: Direct sales of cannabis-based Ayurvedic medicines to patients through e-commerce platform and practitioner network. Products include tablets, churna (powders), and specialized formulations dispensed with medical consultation.
2. Consultation Services: Free and paid consultations with certified Ayurvedic practitioners through the platform, enabling patients to get prescriptions and guidance on cannabis-based treatments.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Hempstreet Medicare is India's first and largest research-to-retail venture in the Ayurvedic medicinal cannabis sector. It develops, manufactures, and dispenses classical Ayurvedic formulations featuring medical cannabis (Vijaya) and other herbal ingredients through a network of 60,000+ certified Ayurvedic practitioners and 18,000+ clinics, with a 300+ formulation portfolio targeting chronic pain, menstrual health, gastrointestinal disorders, hypertension, sexual wellness, and palliative care. Products are dispensed under practitioner prescription, with direct e-commerce availability for patients.

Product overview

Hempstreet Medicare operates as India's first and largest research-to-retail venture in the Ayurvedic medicinal cannabis sector, offering a portfolio of classical Ayurvedic formulations featuring cannabis (Vijaya) and other herbal ingredients. The product lineup centers on Trailokya Vijaya Vati as the flagship formulation for pain management, complemented by digestive health products (Bilwadi Churna), cardiovascular formulations (Sarpagandha Ghan Vati), sexual wellness solutions (Manmath Ras), and specialized offerings like Formulation Humane for cancer pain. The company connects patients to over 60,000 Ayurvedic practitioners through its platform, enabling consultation and dispensation of these cannabis-based medicines with proper medical supervision. The portfolio includes both traditional Ayurvedic preparations (Kameshwar Modaka variants, Sarpagandha Vati) and modern nutraceutical products (ArtemiC mouth spray), addressing conditions ranging from chronic pain and neuropathy to IBS, hypertension, and menstrual health.

Differentiator

Problem solved

Functional benefit

Products and services

• Trailokya Vijaya Vati A potent classical Ayurvedic formulation with Vijaya (medical cannabis) as its key ingredient, used for managing chronic pain, neuropathic pain, post-operative pain, and various inflammatory conditions. It influences cannabinoid receptors in the brain and nervous system to modulate pain response, and is dispensed to patients through certified Ayurvedic practitioners and via the Hempstreet e-commerce storefront with a valid prescription.
• Bilwadi Churna An herbal Ayurvedic concoction used as a Pachaka medicine for digestive health, particularly effective for managing Irritable Bowel Syndrome (IBS) and related digestive disorders, and dispensed via Hempstreet's practitioner network with endocannabinoid-system active components.
• Kameshwar Modaka A highly potent and time-tested herbal Ayurvedic formulation used for pain management and broader therapeutic applications, offered both as a classical preparation and in a tablet dosage form (Kameshwar Modaka Tablet) for more convenient patient use.
• Sarpagandha Ghan Vati A classical Ayurvedic formulation containing Sarpagandha (Rauvolfia serpentina) as the primary ingredient, used for the management of hypertension and related cardiovascular conditions, and dispensed to patients via certified Ayurvedic practitioners.
• Manmath Ras An Ayurvedic formulation designed to enhance sexual wellness, vitality, and stamina, addressing sexual health issues in men and women including libido enhancement and post-menopausal symptoms, dispensed via the Hempstreet practitioner network.
• Formulation Humane A cannabis-based Ayurvedic formulation specifically developed for cancer pain relief, used as part of Hempstreet's focus on palliative care for managing pain in terminal and chronic conditions, and dispensed under practitioner supervision.
• ArtemiC A nutraceutical mouth spray developed in collaboration with MGC Pharma, containing artemisinin and cannabinoids, positioned for patients showing COVID-19 symptoms and introduced under Hempstreet's phytomedicine partnership pipeline.
• Ayurvedic Practitioner Consultation Services Free and paid consultation services with certified Ayurvedic practitioners (BAMS, BHMS qualified) enabling patients to obtain prescriptions, dosing guidance and follow-up support for cannabis-based Ayurvedic medicines, delivered digitally via Hempstreet's platforms and across its 18,000+ partner clinics.

Quantifiable outcome

• 60,000+ Ayurvedic practitioners in network
• +3 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered minor and core.

• myUpcharminorGTM or Marketing Partner · 21 June 2023Hempstreet and myUpchar joined forces to boost awareness and access to cannabis-based medicines to tackle mass ailments in India. myUpchar provides platform reach and content capabilities for patient education and awareness campaigns.
• Amrita School of AyurvedacoreStrategic or Co-development Partner · 9 August 2022Medical cannabis startup HempStreet partnered with Amrita School of Ayurveda to build solutions for mass ailments. Partnership includes conducting India's first clinical trials for menstrual cramps using cannabis-based medicines. Collaborative research efforts to validate Ayurvedic cannabis formulations.
• MGC PharmacoreStrategic or Co-development Partner · 4 May 2022HempStreet announced partnership with MGC Pharma to revolutionize global phytomedicine sector. Collaboration led to launch of ArtemiC, a nutraceutical mouth spray for COVID-19 patients. MGC Pharma provides pharmaceutical expertise while HempStreet contributes market access in India.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Bombay Hemp Company (BOHECO): BOHECO is one of India's pioneering industrial hemp and medicinal cannabis companies, similarly combining research, cultivation, and consumer/retail distribution. Directly comparable as an Indian hemp/cannabis research-to-retail peer.
• MGC Pharma: Australia-listed phytopharmaceutical and medicinal cannabis company, Hempstreet's strategic partner for ArtemiC. Operates in the same phytomedicine/cannabinoid therapeutics space with overlapping products targeting inflammation, pain, and infectious disease.
• Hempstrol: Indian hemp-derived wellness and CBD retailer offering cannabis/hemp-based therapeutic products online. Comparable as a domestic DTC hemp wellness brand competing for similar Indian consumers seeking cannabinoid-based relief.
• Awshad: India-based cannabis wellness brand retailing CBD/hemp-derived oils, skincare, and pain formulations via DTC channels. Closely comparable to Hempstreet on product mix, distribution model, and target patient segments.
• India Hemp & Co: Indian hemp-derived wellness retailer offering CBD oils, skincare, and food products through DTC e-commerce. Comparable as an Indian hemp/cannabis wellness brand targeting similar urban consumers and wellness use cases.
• Satya (Cannabis Wellness): India-based Ayurvedic cannabis wellness brand offering prescription-based cannabinoid formulations. Directly comparable business model pairing practitioner dispensing with Ayurvedic positioning in the Indian market.

Broad incumbents

• Tilray Brands: Large global cannabis company with medical cannabis, wellness, and pharmaceutical operations across multiple continents. Comparable as a broad incumbent in the medicinal cannabis space Hempstreet occupies, though at far larger scale and with international footprint.
• Canopy Growth: Global cannabis incumbent with medical cannabis and cannabinoid-based pharmaceutical products. Overlaps with Hempstreet's therapeutic-cannabis positioning and serves as a benchmark for the global medicinal cannabis industry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/HempStreetIndia
• YouTubeyoutube.com/channel/UCf4KTTNwinSDnitDH6FKTmw
• Facebookfacebook.com/HempStreetIndia
• LinkedInlinkedin.com/company/hempstreetindia
• Instagraminstagram.com/hempstreet1.0
• Pinterestin.pinterest.com/Hempstreet

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hempstreet Medicare